Comparison of Incident Dyspepsia Between Low-Dose Plain Aspirin and Enteric-Coated Aspirin

Clinical Gastroenterology and Hepatology

Volumn 8, Issue 4, 2010, Pages 395-

  van Oijen, Martijn G H ^a   Focks, Jeroen Jaspers ^a   Laheij, Robert J F ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

CLINICAL TRIAL; COMPARATIVE STUDY; DYSPEPSIA; HUMAN; INCIDENCE; LETTER; LOW DRUG DOSE; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; ASPIRIN; CHEMISTRY, PHARMACEUTICAL; DYSPEPSIA; HUMANS; INCIDENCE;

EID: 77949655692     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.10.006     Document Type: Letter

References (6)

1. Arora G., Singh G., and Triadafilopoulos G. Proton pump inhibitors for gastroduodenal damage related to nonsteroidal anti-inflammatory drugs or aspirin: twelve important questions for clinical practice. Clin Gastroenterol Hepatol 7 (2009) 725-735
2. Blondon H., Barbier J.P., Mahé I., et al. Gastroduodenal tolerability of medium dose enteric-coated aspirin: a placebo controlled endoscopic study of a new enteric-coated formulation versus regular formulation in healthy volunteers. Fundam Clin Pharmacol 14 (2000) 155-157
3. Chowdhury A., Ganguly G., Chowdhury D., et al. Gastro-duodenal mucosal changes associated with low-dose aspirin therapy: a prospective, endoscopic study. Indian J Gastroenterol 20 (2001) 227-229
4. Cole A.T., Hudson N., Liew L.C., et al. Protection of human gastric mucosa against aspirin-enteric coating or dose reduction?. Aliment Pharmacol Ther 13 (1999) 187-193
5. Dammann H.G., Burkhardt F., and Wolf N. Enteric coating of aspirin significantly decreases gastroduodenal mucosal lesions. Aliment Pharmacol Ther 13 (1999) 1109-1114
6. Petroski D. Endoscopic comparison of three aspirin preparations and placebo. Clin Ther 15 (1993) 314-320